212 related articles for article (PubMed ID: 21718248)
1. Drug-induced cardiac mitochondrial toxicity and protection: from doxorubicin to carvedilol.
Pereira GC; Silva AM; Diogo CV; Carvalho FS; Monteiro P; Oliveira PJ
Curr Pharm Des; 2011; 17(20):2113-29. PubMed ID: 21718248
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy.
Santos DL; Moreno AJ; Leino RL; Froberg MK; Wallace KB
Toxicol Appl Pharmacol; 2002 Dec; 185(3):218-27. PubMed ID: 12498738
[TBL] [Abstract][Full Text] [Related]
3. Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity.
Oliveira PJ; Bjork JA; Santos MS; Leino RL; Froberg MK; Moreno AJ; Wallace KB
Toxicol Appl Pharmacol; 2004 Oct; 200(2):159-68. PubMed ID: 15476868
[TBL] [Abstract][Full Text] [Related]
4. Are the antioxidant properties of carvedilol important for the protection of cardiac mitochondria?
Oliveira PJ; Gonçalves L; Monteiro P; Providencia LA; Moreno AJ
Curr Vasc Pharmacol; 2005 Apr; 3(2):147-58. PubMed ID: 15853634
[TBL] [Abstract][Full Text] [Related]
5. Carvedilol: just another Beta-blocker or a powerful cardioprotector?
Carreira RS; Monteiro P; Gon Alves LM; Providência LA
Cardiovasc Hematol Disord Drug Targets; 2006 Dec; 6(4):257-66. PubMed ID: 17378771
[TBL] [Abstract][Full Text] [Related]
6. Early Administration of Carvedilol Protected against Doxorubicin-Induced Cardiomyopathy.
Chen YL; Chung SY; Chai HT; Chen CH; Liu CF; Chen YL; Huang TH; Zhen YY; Sung PH; Sun CK; Chua S; Lu HI; Lee FY; Sheu JJ; Yip HK
J Pharmacol Exp Ther; 2015 Dec; 355(3):516-27. PubMed ID: 26511374
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol and antioxidant proteins in a type I diabetes animal model.
Diogo CV; Deus CM; Lebiedzinska-Arciszewska M; Wojtala A; Wieckowski MR; Oliveira PJ
Eur J Clin Invest; 2017 Jan; 47(1):19-29. PubMed ID: 27805735
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of heart mitochondrial lipid peroxidation by non-toxic concentrations of carvedilol and its analog BM-910228.
Santos DJ; Moreno AJ
Biochem Pharmacol; 2001 Jan; 61(2):155-64. PubMed ID: 11163330
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol protects ischemic cardiac mitochondria by preventing oxidative stress.
Carreira R; Duarte A; Monteiro P; Santos MS; Rego AC; Oliveira CR; Gonçalves LM; Providência LA
Rev Port Cardiol; 2004 Nov; 23(11):1447-55. PubMed ID: 15693697
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol inhibits mitochondrial complex I and induces resistance to H2O2 -mediated oxidative insult in H9C2 myocardial cells.
Sgobbo P; Pacelli C; Grattagliano I; Villani G; Cocco T
Biochim Biophys Acta; 2007 Mar; 1767(3):222-32. PubMed ID: 17346667
[TBL] [Abstract][Full Text] [Related]
11. Carvedilol reduces mitochondrial damage induced by hypoxanthine/xanthine oxidase: relevance to hypoxia/reoxygenation injury.
Oliveira PJ; Rolo AP; Palmeira CM; Moreno AJ
Cardiovasc Toxicol; 2001; 1(3):205-13. PubMed ID: 12213973
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.
Hao E; Mukhopadhyay P; Cao Z; Erdélyi K; Holovac E; Liaudet L; Lee WS; Haskó G; Mechoulam R; Pacher P
Mol Med; 2015 Jan; 21(1):38-45. PubMed ID: 25569804
[TBL] [Abstract][Full Text] [Related]
13. Effects of Administered Cardioprotective Drugs on Treatment Response of Breast Cancer Cells.
Smith TA; Phyu SM; Akabuogu EU
Anticancer Res; 2016 Jan; 36(1):87-93. PubMed ID: 26722031
[TBL] [Abstract][Full Text] [Related]
14. Anti-oxidants and apoptosis: attenuation of doxorubicin induced cardiomyopathy by carvedilol.
Armstrong SC
J Mol Cell Cardiol; 2004 Oct; 37(4):817-21. PubMed ID: 15380672
[No Abstract] [Full Text] [Related]
15. Carvedilol as a protector against the cardiotoxicity induced by anthracyclines (doxorubicin).
Machado V; Cabral A; Monteiro P; Gonçalves L; Providência LA
Rev Port Cardiol; 2008 Oct; 27(10):1277-96. PubMed ID: 19178029
[TBL] [Abstract][Full Text] [Related]
16. Advantages in the use of carvedilol versus propranolol for the protection of cardiac mitochondrial function.
Oliveira PJ; Rolo AP; Sardão VA; Monteiro P; Gonçalves L; Providência LA; Palmeira CM; Moreno AJ
Rev Port Cardiol; 2004 Oct; 23(10):1291-8. PubMed ID: 15641294
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of carvedilol against doxorubicin-induced cardiomyopathy in rats.
Matsui H; Morishima I; Numaguchi Y; Toki Y; Okumura K; Hayakawa T
Life Sci; 1999; 65(12):1265-74. PubMed ID: 10503942
[TBL] [Abstract][Full Text] [Related]
18. The beneficial role of exercise in mitigating doxorubicin-induced Mitochondrionopathy.
Marques-Aleixo I; Santos-Alves E; Oliveira PJ; Moreira PI; Magalhães J; Ascensão A
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):189-199. PubMed ID: 29408395
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy.
Wallace KB; Sardão VA; Oliveira PJ
Circ Res; 2020 Mar; 126(7):926-941. PubMed ID: 32213135
[TBL] [Abstract][Full Text] [Related]
20. Carvedilol inhibits the mitochondrial permeability transition by an antioxidant mechanism.
Oliveira PJ; Esteves T; Rolo AP; Palmeira CM; Moreno AJ
Cardiovasc Toxicol; 2004; 4(1):11-20. PubMed ID: 15034201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
